Interact to see
Advertisement
Advertisement
ADNRX vs RPMGX
ADNRX vs RPMGX Comparison
Open Charts ADNRX vs RPMGX
American Beacon ARK Transfmt Innov R6
Price$24.16
Change-$0.46 (-1.87%)
VolumeN/A
Net Assets243.85M
T. Rowe Price Mid-Cap Growth
Price$102.26
Change-$1.14 (-1.10%)
VolumeN/A
Net Assets26.99B
ADNRX vs RPMGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. RPMGX commentary
Oct 09, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and RPMGX is a Buy.
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 27B vs. ADNRX (244M). ADNRX (0.00) and RPMGX (0.00) have matching dividends . ADNRX was incepted earlier than RPMGX: ADNRX (5 years) vs RPMGX (33 years). ADNRX (1.13) is less costly to investors than RPMGX (0.75). ADNRX is a more actively managed with annual turnover of: 38.00 vs. RPMGX (22.60). ADNRX has a lower initial minimum investment than RPMGX: ADNRX (0) vs RPMGX (2500). ADNRX annual gain was more profitable for investors over the last year : 94.93 vs. RPMGX (-4.11).
| ADNRX | RPMGX | ADNRX / RPMGX | |
| Total Expense Ratio | 1.00 | 0.75 | 133% |
| Annual Report Gross Expense Ratio | 1.13 | 0.75 | 151% |
| Fund Existence | 5 years | 33 years | - |
| Gain YTD | 57.922 | 3.680 | 1,574% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 244M | 27B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 94.93 | -4.11 | -2,311% |
| Returns for 3 years | 122.60 | 20.56 | 596% |
| Returns for 5 years | N/A | -2.21 | - |
| Returns for 10 years | N/A | 30.25 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers